Search PubMed⌕ Search

Biomedical subjects

H O Andersen

Publications and source records attributed to H O Andersen.

23 records · Page 2Linked to original sources
PubMed1989

[Meconium ileus equivalent].

Meconium ileus equivalent (MIE) can be defined as a clinical manifestation in cystic fibrosis (CF) patients caused by acute intestinal obstruction by putty-like faecal material in the cecum or terminal ileum. A broader definition includes a more chronic condition in CF patients with abdominal pain and a coecal mass which may eventually pass spontaneously. The condition occurs only in CF patients with exocrine pancreatic insufficiency (EPI). It has not been seen in other CF patients nor in non-CF patients with EPI. The frequency of these symptoms has been reported as 2.4%-25%. Pathophysiologically, MIE is probably caused by a combination of EPI, increased intestinal transit time, and abnormal intestinal mucus. The treatment should primarily be non-operative. Specific treatment with N-acetylcysteine, administrated orally and/or as an enema is recommended. Enemas with the water soluble contrast medium, meglucamine diatrizoate (Gastrografin), provide an alternative form for treatment and can also serve diagnostic purposes. It is important that the physician is familiar with this disease entity and the appropriate treatment with the above mentioned drugs. Non-operative treatment is often effective, and dangerous complications following surgery can thus be avoided.

Adult↗
PubMed1989

Segmental pancreatic autotransplantation in the pig.

The pig has been considered unsuitable for experimental pancreatic transplantation. In order to develop a model for segmental transplantation, the vascular anatomy was studied in 41 pigs. No variation in venous drainage of the pancrease was found. In contrast, 3 variations of arterial supply were noted. In 29 of the pigs (71% [95% confidence limits 64-84]), 1 main pancreatic artery to the body and tail of pancreas arose from the splenic artery about 1-2 cm from its origin from the coeliac trunk (type 1). In 6 pigs (14.5%, 6.5-29.2), 1 main pancreatic artery emerged from the splenic artery very close to its origin from coeliac trunk (type 2). In 6 pigs (14.5%, 6.5-29.2), the only pancreatic artery supplying the body and tail of pancreas came from the common hepatic artery (type 3). Taking the vascular anatomy into account, 37 pigs were totally pancreatectomized and autotransplanted segmentally. The graft consisted of the body and tail and corresponded to approximately 60% of the entire gland. The pancreatic duct was occluded with neoprene. The left kidney was removed in all animals. In 19 of the grafts, the venous drainage was to the portal vein. In the remaining 18, the renal vessels were used for vascular anastomosis to the graft. The success rate was 68.42% and 72.22%, respectively. The median follow-up was 9 months (3-15). All transplanted pigs were normoglycemic. It is concluded that the pig is suitable for experimental pancreatic autotransplantation studies if the vascular variations are adequately dealt with.

Animals↗
PubMed1989

Pharmacokinetics and metabolism of neurotensin in man.

We studied the pharmacokinetics, arteriovenous extraction, and degradation sites of neurotensin (NT) in man during iv infusions of synthetic intact NT [NT-(1-13)] and the NH2-terminal metabolite NT-(1-8) during lipid ingestion and by catheterization of various vascular beds in normal subjects and patients with hepatic disease. NT-like immunoreactivities in plasma were quantitated using 2 sequence-specific RIAs and gel filtration chromatography. During iv infusion of NT-(1-13) in 6 normal subjects, the median t1/2 was 1.7 min (interquartile range, 0.7-2.8), the MCR was 36 mL/kg.min (range, 21-54), and distribution space was 78.8 mL/kg (range, 56-91). The results were similar at infusion rates of 72, 144, and 288 pmol/kg.h (n = 6). During infusion of NT-(1-8) in 7 normal subjects, the median t1/2 was 8.3 min (range, 4.7-13.8), the MCR was 11.0 mL/kg.min (range, 6.7-21.7), and the distribution space was 142.6 mL/kg (range, 45.3-281.0). Significant peripheral arteriovenous extraction of NT-(1-13) was found at infusion rates of 144 and 288 pmol/kg.h. Extraction of NH2-terminal immunoreactivity was not significant. Intact NT was identified by gel chromatography in arterial plasma after lipid ingestion and iv infusion of NT-(1-13), but postprandially in only low concentrations. In 17 patients with various nonhepatic diseases, plasma intact NT levels were not different in blood sampled from the renal vein, inferior vena cava, brachial artery, or hepatic vein. In contrast, NH2-terminal immunoreactivity was significantly higher in hepatic venous than in systemic plasma. In 6 patients with hepatic disease, systemic plasma intact NT levels were increased, but even more so in hepatic venous plasma. These results demonstrate that metabolism of intact NT is rapid, and a significant peripheral arterio-venous extraction is present. Further studies are necessary to establish if the liver is a site of degradation of intact NT in man.

Adult↗